Nora Hagelberg

Turku University Hospital — Finland

Medicine · Health Sciences

36h-index3.8kcitations68works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Mechanisms and Treatments(20), Pain Management and Opioid Use(18), Pharmacogenetics and Drug Metabolism(10), Neurotransmitter Receptor Influence on Behavior(9), Anesthesia and Sedative Agents(9)

Publications68 total

Feasibility of a transmucosal sublingual fentanyl tablet as a procedural pain treatment in colonoscopy patients: a prospective placebo-controlled randomized study
Scientific Reports·2020· 2 citedOpen Access
Machine learning suggests sleep as a core factor in chronic pain
Pain·2020· 43 citedOpen Access
Voriconazole greatly increases the exposure to oral buprenorphine
European Journal of Clinical Pharmacology·2018· 14 citedOpen Access
Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brain
European Journal of Pharmacology·2018· 70 citedOpen Access
Acute pain intensity monitoring with the classification of multiple physiological parameters
Journal of Clinical Monitoring and Computing·2018· 85 citedOpen Access
Ultra-short-term analysis of heart rate variability for real-time acute pain monitoring with wearable electronics
2017· 26 cited
Validation of EQ-5D and 15D in the assessment of health-related quality of life in chronic pain
Pain·2017· 74 cited
Neurotransmitters behind pain relief with transcranial magnetic stimulation – positron emission tomography evidence for release of endogenous opioids
European Journal of Pain·2017· 76 citedOpen Access
Transkraniaalinen magneettistimulaatio neuropaattisen kivun hoidossa
Työväentutkimus Vuosikirja·2017Open Access
Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects
Pharmacology Research & Perspectives·2016· 11 citedOpen Access
The analgesic effect of therapeutic rTMS is not mediated or predicted by comorbid psychiatric or sleep disorders
Medicine·2016· 22 citedOpen Access
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction
European Journal of Clinical Pharmacology·2016· 16 citedOpen Access
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Clinical Pharmacokinetics·2016· 616 cited
[Update on current care guidelines. Pain].
PubMed·2016
Right secondary somatosensory cortex—a promising novel target for the treatment of drug-resistant neuropathic orofacial pain with repetitive transcranial magnetic stimulation
Pain·2015· 91 cited
Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol
European Journal of Clinical Pharmacology·2015· 36 cited
[Can we prevent pain becoming chronic?].
PubMed·2015· 1 cited
Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation
Pain·2014· 77 cited
P656: S2 cortex – a promising novel target for the treatment of neuropathic pain with rTMS
Clinical Neurophysiology·2014· 4 cited
S.02.02 Dopamine D2 and serotonin 5-HT1A receptors of the brain in processing of pain
European Neuropsychopharmacology·2013
page 1 of 4Next →

Frequent Co-authors

Klaus T. Olkkola(24), Teijo I. Saari(22), Pertti J. Neuvonen(22), Kari Laine(21), Jarmo Hietala(16), Kjell Någren(13), Antti Pertovaara(13), Harry Scheinin(12), Ilkka K. Martikainen(9), Mikko Neuvonen(9), Heli Forssell(8), Sargo Aalto(8), Satu K. Jääskeläinen(8), Tero Taiminen(7), Tuija H. Nieminen(6), Marko Peltoniemi(5), Heikki Mansikka(5), Juha Grönlund(5), Jussi Hirvonen(5), Jaana Kajander(5)